Shabnam Kazmi

Shabnam Kazmi has 25+ years experience leading strategy and innovation, new drug development, commercialization and launch of specialty medicines, global business management, patient access, nonprofit board management, and licensing and alliance management. Across US, French, Japanese companies and global partnerships, Shabnam has a proven track record for bridging cultures to drive business performance. Leading cross-functional strategic and operational initiatives, mergers and acquisitions, and large complex projects Shabnam is known for driving corporate revenue growth while maximizing positive outcomes for patients.